Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2022.1124440 Immunology Correction Corrigendum: Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance Shirane Mariko 1 Yawata Nobuyo 2 3 4 * Motooka Daisuke 5 6 Shibata Kensuke 2 7 8 Khor Seik-Soon 9 Omae Yosuke 9 Kaburaki Toshikatsu 10 11 Yanai Ryoji 12 Mashimo Hisashi 13 Yamana Satoshi 1 Ito Takako 1 Hayashida Akira 1 Mori Yasuo 14 Numata Akihiko 14 Murakami Yusuke 1 Fujiwara Kohta 1 Ohguro Nobuyuki 13 Hosogai Mayumi 15 Akiyama Masato 2 Hasegawa Eiichi 1 Paley Michael 16 Takeda Atsunobu 1 Maenaka Katsumi 17 18 19 Akashi Koichi 14 Yokoyama Wayne M. 16 20 Tokunaga Katsushi 9 Yawata Makoto 21 22 23 24 25 26 Sonoda Koh-Hei 1 1 Department of Ophthalmology, Kyushu University, Fukuoka, Japan 2 Department of Ocular Pathology and Imaging Science, Kyushu University, Fukuoka, Japan 3 Ocular inflammation and Immunology, Singapore Eye Research Institute, Singapore, Singapore 4 Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore 5 Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan 6 Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Osaka, Japan 7 Department of Microbiology and Immunology, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan 8 Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan 9 Genome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan 10 Department of Ophthalmology, The University of Tokyo Hospital, Tokyo, Japan 11 Department of Ophthalmology, Jichi Medical University Saitama Medical Center, Saitama, Japan 12 Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan 13 Department of Ophthalmology, Japan Community Health Care Organization Hospital, Osaka, Japan 14 Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan 15 Department of Ophthalmology, Gunma University Graduate School of Medicine, Gunma, Japan 16 Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States 17 Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan 18 Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan 19 Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Sapporo, Japan 20 Bursky Center for Human Immunology and Immunotherapy Programs, Washington University, St. Louis, MO, United States 21 Singapore Institute for Clinical Sciences (SICS), Agency for Science, Technology and Research, ASTAR, Singapore, Singapore 22 Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore 23 Department of Pediatrics, National University Health System, Singapore, Singapore 24 Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore 25 National University Singapore Medicine Immunology Translational Research Programme, National University of Singapore, Singapore, Singapore 26 International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan

Edited and Reviewed by: Michael G. Brown, University of Virginia, United States

*Correspondence: Nobuyo Yawata, yawata.nobuyo.718@m.kyushu-u.ac.jp

This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology

 05 01 2023 2022 13 1124440 15 12 2022 16 12 2022 Copyright © 2023 Shirane, Yawata, Motooka, Shibata, Khor, Omae, Kaburaki, Yanai, Mashimo, Yamana, Ito, Hayashida, Mori, Numata, Murakami, Fujiwara, Ohguro, Hosogai, Akiyama, Hasegawa, Paley, Takeda, Maenaka, Akashi, Yokoyama, Tokunaga, Yawata and Sonoda 2023 Shirane, Yawata, Motooka, Shibata, Khor, Omae, Kaburaki, Yanai, Mashimo, Yamana, Ito, Hayashida, Mori, Numata, Murakami, Fujiwara, Ohguro, Hosogai, Akiyama, Hasegawa, Paley, Takeda, Maenaka, Akashi, Yokoyama, Tokunaga, Yawata and Sonoda

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance by Shirane M, Yawata N, Motooka D, Shibata K, Khor S-S, Omae Y, Kaburaki T, Yanai R, Mashimo H, Yamana S, Ito T, Hayashida A, Mori Y, Numata A, Murakami Y, Fujiwara K, Ohguro N, Hosogai M, Akiyama M, Hasegawa E, Paley M, Takeda A, Maenaka K, Akashi K, Yokoyama WM, Tokunaga K, Yawata M and Sonoda K-H (2022) Front. Immunol. 13:1008220. doi: 10.3389/fimmu.2022.1008220 human cytomegalovirus HLA-E UL40 natural killer cells HLA class I NKG2A CMV viremia CMV retinitis

In the published article, there were errors. In the original article, there was an error in the description of the Reverse primer sequence in Materials and methods.

A correction has been made to Materials and methods, “Deep amplicon sequencing of CMV-UL40 genomic DNA”.

This sentence previously stated:

“The following forward and reverse primers were used: Forward, 5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCAACAGTCGGCAGAATGAAC-3′ and Reverse, 5′-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTGGAACACGACGCATA-3’.”

The corrected sentence appears below:

“The following forward and reverse primers were used: Forward, 5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCAACAGTCGGCAGAATGAAC-3′ and Reverse, 5′-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGCTGGAACACGAGCGGACATA-3’.”

In the original article, there was another error in the description of the concentration of the anti-HLA-E antibody in Materials and methods.

A correction has been made to Materials and methods, “Immunohistochemistry analysis”.

This sentence previously stated:

“After antigen retrieval with boiling citrate buffer (pH 6.0), the sections were incubated with 5% skim milk for 1 h at room temperature to prevent nonspecific binding and stained with 10 μL/mL anti-HLA-E antibody [MEM-E/02] (Abcam; Cambridge, UK) or IgG from mouse serum (Sigma-Aldrich) overnight at 4°C.”

The corrected sentence appears below:

“After antigen retrieval with boiling citrate buffer (pH 6.0), the sections were incubated with 5% skim milk for 1 h at room temperature to prevent nonspecific binding and stained with 10 μg/mL anti-HLA-E antibody [MEM-E/02] (Abcam; Cambridge, UK) or IgG from mouse serum (Sigma-Aldrich) overnight at 4°C.”

The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.